Kidney Failure

Nocturnal systolic hypertension conferred a higher likelihood of adverse kidney and cardiovascular outcomes in patients with chronic kidney disease, according to a study that compared different nocturnal hypertension entities.

The National Kidney Foundation has launched a clinical tool that assesses chronic kidney disease in pediatric patients, thereby allowing for improved predictions of disease progression.

For patients with non-valvular atrial fibrillation, study results showed treatment with apixaban was associated with a lower risk for chronic kidney disease progression compared with warfarin.

A majority of patients with kidney failure were deemed ready for increased utilization of mobile health based on reported availability of necessary devices, as well as proficiency and interest in the technology.

Findings from the 2018 Global Kidney Health Atlas survey showed that although conservative management for kidney disease is available in most countries, the quality and accessibility of care varies.

Contending that “no clear guidance exists” regarding depression screening for patients with kidney failure, researchers determined there is also limited research assessing the accuracy of available tools.

Dapagliflozin reduced the worsening of kidney function and the risk of cardiovascular or renal death in patients with chronic kidney disease irrespective of the underlying cause of kidney disease, according to recently presented data.

From 2008 to 2015, prescriptions for vitamin D sterols trended downward while prescriptions for phosphate binders and cinacalcet increased for patients with kidney failure at 359 facilities affiliated with Dialysis Clinic Inc.

For patients with both heart and kidney failure, beta-blocker use was associated with decreased mortality rates within 1 year after dialysis initiation.

Adults who receive maintenance hemodialysis 2 or more times per week expressed interest in an online patient community that includes access to a registered dietitian, according to survey results.